Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality?

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde

Volumn 100, Issue 9, 2010, Pages

  Boulle, Andrew ^a   Clayden, Polly ^b   Cohen, Karen ^b   Cohen, Ted ^b   Conradie, Francesca ^b   Dong, Krista ^b   Geffen, Nathan ^b   Grimwood, Ashraf ^b   Hurtado, Rocio ^b   Kenyon, Christopher ^b   Lawn, Stephen ^b   Maartens, Gary ^b   Meintjes, Graeme ^b   Mendelson, Marc ^b   Murray, Megan ^b   Rangaka, Molebogeng ^b   Sanne, Ian ^b   Spencer, David ^b   Taljaard, Jantjie ^b   Variava, Ebrahim ^b   Venter, W D Francois ^b   Wilson, Douglas ^b   more..

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT;

AIDS RELATED COMPLEX; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; DRUG ADMINISTRATION; ETHICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MICROBIOLOGY; MORTALITY; SOUTH AFRICA; THERAPEUTIC EQUIPOISE; TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; SOUTH AFRICA; THERAPEUTIC EQUIPOISE; TUBERCULOSIS;

MLCS; MLOWN;

EID: 78149475069     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.4434     Document Type: Article

References (0)